Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells. [electronic resource]
Producer: 20090918Description: 782-91 p. digitalISSN:- 1532-1827
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cetuximab
- Cobalt Radioisotopes
- Combined Modality Therapy
- Enzyme Inhibitors -- pharmacology
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Kinetics
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Phosphorylation
- RNA, Messenger -- biosynthesis
- Reverse Transcriptase Polymerase Chain Reaction
- Sensitivity and Specificity
- Trastuzumab
- Uterine Cervical Neoplasms -- drug therapy
- Vascular Endothelial Growth Factors -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.